Envoy Medical begins 1-for-10 reverse stock split effective October 26, 2026
Envoy Medical (COCH) completed a 1-for-10 reverse stock split, effective 12:01 a.m. Eastern Time on October 26, 2026, and its shares began trading on a post-split basis on the Nasdaq Capital Market that day. The company said the split is intended to maintain compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing, and that it may improve trading liquidity.
Key points
- Stockholders approved the split at a special meeting on October 12, 2026; the board set the ratio at 1-for-10 on the same date, within an approved range of 1-for-5 to 1-for-25.
- Every 10 issued and outstanding shares were combined into one share; fractional shares will be paid in cash.
- The ticker remains COCH; the new CUSIP number is 29415V307.
- The number of authorized shares and the par value per share are unchanged.
The filing
Written by AI on Nov 9, 2026, 11:45 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 27, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.